Optimal management of T2DM remains elusive

被引：0
|
作者：
Rury R. Holman
机构：
[1] Diabetes Trials Unit,
[2] The Oxford Centre for Diabetes,undefined
[3] Endocrinology and Metabolism,undefined
[4] University of Oxford,undefined
[5] Churchill Hospital,undefined
来源：
Nature Reviews Endocrinology | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Worldwide, >366 million people with type 2 diabetes mellitus remain at excess risk of cardiovascular disease and face a lifetime of treatment escalation for this progressive disorder. Studies in 2012 have re-affirmed the safety of early insulin treatment, metformin use in renal impairment, and shown β-cell function preservation over several years.
引用
下载
收藏
页码：67 / 68
页数：1
相关论文
共 50 条
12345